Clinical Trial Detail

NCT ID NCT02265536
Title A Study of LY3022855 In Participants With Breast or Prostate Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Eli Lilly and Company
Indications

breast cancer

prostate cancer

Therapies

LY3022855

Age Groups: adult

No variant requirements are available.